A new analysis reveals that the antidepressant Sertraline can lead to early improvements in Depression (mood) and Anxiety symptoms within two weeks, highlighting its potential effectiveness.
- The study, published in Nature Mental Health, shows that Sertraline improves Depression (mood) and Anxiety symptoms, with effects noticeable within just two weeks.
- Conducted by UCL researchers, the analysis of the PANDA clinical trial indicates Sertraline may alleviate Anxiety symptoms faster than Depression (mood) symptoms.
- Findings from the 2019 PANDA trial also address potential Side effects, including impacts on Libido and the risk of Suicidal ideation among users of Sertraline.
Why It Matters
Sertralines early effectiveness in addressing Anxiety and Depression (mood) could reshape treatment approaches for mental health, encouraging timely interventions and improving patient outcomes in clinical psychiatry.